Carboxymethylated beta-1,3-glucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages in vitro and modulates their plasma clearance in vivo

Cell Biochemistry and Function

Volumn 14, Issue 3, 1996, Pages 209-217

  Dushkin, Michail I ^a   Safina, Alfija F ^a   Vereschagin, Evgenij I ^b   Schwartz, Yakov S H ^b  

^a Institute of Internal Medicine   (Russian Federation)

^b SB RAMS   (Russian Federation)

Author keywords

Acetylated low density lipoprotein; Foam cells; Glucans; Macrophages; Scavenger receptor

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; BETA 1,3 GLUCAN; GLUCAN; IODINE 125; MANNAN; POLYSACCHARIDE; SCAVENGER; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARBOXYLATION; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; LIPOPROTEIN METABOLISM; LIVER CLEARANCE; METHYLATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALIA; MURINAE;

EID: 0029798171     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.685     Document Type: Article

References (35)

1. Chorvatovikova, D. and Sandula, J. (1994). Antimutagenic effect of glucans. Abstracts of 7th Bratislava Symposium on Saccharides, 55-56.
2. Goldstein, J. L. and Brown, M. S. (1990). Scavenging for receptors. Nature, 343, 425-430.
3. Brown, M. S. and Goldstein, J. L. (1983). Lipoprotein metabolism in the macrophage: Implication for cholesterol deposition in atherosclerosis Anna. Rev. Biochem., 52, 223-261.
4. Krieger, M. (1992). Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. Trends Biochem. Sci., 17, 141-146.
5. Mon, T., Takahashi, K., Naito, M., Kodama, T., Hakamata, H., Sakai, M., Miyazaki, A., Horiuchi, S. and Ando, M. (1994). Endocytic pathway of scavenger receptors via trans-Golgi system in bovine alveolar macrophages Lab. Invest., 71, 409-416.
6. Steinbrecher, U. P., Longheed, M., Kwan, W. C. and Dirks, M. (1989). Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from dérivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem., 264, 15216-15223.
7. Holvoet, P., Ferez, G., Bernar, H., Brouwers, E., Vanloo, B., Rosseneu, M. and Collen, D. (1994). Stimulation with a monoclonal antibody of scavenger receptor-mediated uptake of chemically modified LDL by THP-1-derived macrophages enhances foam cell generation J. Clin, litres!., 93, 89-98.
8. Lopes-Virella, M. F., Klein, R. L. and Stevenson, H. C. (1987). LDL metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis,!, 176-184.
9. Leake, D. S., May, G., Soyombo, A. A. and Nasr-Esfahani, M. H. (1989). Effect of macrophage stimulation on the uptake of acetylated LDL. Biochem. Biophys. Acta., 1005, 196-200.
10. Via, P. P., Pons, L., Dennison, D. K., Fanslow, A. E. and Bernini, F. (1989). Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1. J. LipidRes., 30, 1515-1524.
11. Fong, L. A., Fong, T. A. and Cooper, A. D. (1990). Inhibition of mouse macrophage degradation of acetylLDL by interferon-gamma. J. Biol. Chem., 265, 1175111760.
12. Geng, I.-J. and Hansson, A. K. (1992). Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest., 89, 1322-1330.
13. Van Lenten, B. J. and Fogelman, A. M. (1992). Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor. J. Immtmol., 148, 112-116.
14. de Villiers, W. J. S., Fraser, J. P., Hughes, D. A. and Gordon, S. (1995). Macrophage adhesion in atherosclerosis: a role for the scavenger receptor? In: Atherosclerosis 10. Proceedings of the Tenth International Symposium on Atherosclerosis. (Woodford, F. P., Davignon, J. and Sniderman, A., eds.) Elsevier: Amsterdam, Lousanne, New York, Oxford, Shannon, Tokyo, pp. 593-597.
15. Cai, H. J., He, Z. G. and Ding, Y. N. (1988). Effect of monocyte macrophages stimulation on hepatic lipoprotein receptors. Biochim. Biophys. Acta, 958, 334-342.
16. Dushkin, M. L, Zenkov N. K., Menshikova E. B., Pivovarova E. N., Lyubimov G. Yu and Volsky N. N. (1995). Ketoconazole inhibits oxidative modification of low density lipoprotein. Atherosclerosis, 114, 9-18.
17. Dushkin, M. I. and Schwartz, J. Sh. (1995) Effect of verapamil and nifedipine on cholesteryl ester metabolism and low density lipoprotein oxidation in macrophages. Biochem. Pharm., 49, 389-397.
18. Havel, R. J., Eder, H. A. and Bragdon, J. H. (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest., 34, 1345-1353.
19. McFarlane, A. S. (1958). Efficient trace labeling of proteins with iodine. Nature, 182, 53-54.
20. Bilheimer, D. W., Eisenberg, G. and Levy, R. J. (1972). The metabolism of very low density lipoproteins 1. Preliminary in vitro and in vivo observations. Biochim. Biophys. Ada, 260, 212-221.
21. Goldstein, J. L., Ho, Y. K., Basu, S. K. and Brown, M. S. (1979). Binding site on macrophages that mediates uptake and degradation of acetylated LDL, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U.S.A., 76, 333337.
22. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
23. Duncan, D. B. (1995). Multiple range and multiple F test. Biometrics, 11, 1-42.
24. Snedecor, G. W. and Cochram, W. G. (1981). Statistical Methods, 7th edn. Iowa Press: Ames, JA, pp. 91-93.
25. Gianturco, S. H., Bradley, W. A., Gotto, A. M., Morrisett, S. D. and Peavy, D. L. (1982). Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J. Clin. Invest., 70, 168-178.
26. Levis, G. P. (1986). Mediators of Inflammation. Wright: Bristol, pp. 77-83.
27. Hampton, R. Y., Golenbock, D. T., Penman, M., Krieger, M. and Raetz, C. R. H. (1991). Recognition and plasma clearance of endotoxin by scavenger receptors. Nature, 352, 342-344.
28. Xu, X., Remold, H. G. and Caulfield, J. P. (1993). Potential role for scavenger receptors of human monocytes in the killing of Schistosoma mansoni. Am. J. Pathol., 142, 685689.
29. Freeman, M., Ashkenas, J., Rees, D. J. G., Kingsley, D. M., Copeland, N. G., Jenkins, N. A. and Krieger, M. (1990). An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc. Nail. Acad. Sci. U.S.A., 87, 8810-8814.
30. Matsumoto, A., Naito, M., Itakura, H., Ikemoto, S., Asaoka, H., Hayakawa, I., Kanamori, H., Aburatani, H., Takaku, F., Suzuki, H., Kobari, Y., Miyai, T., Takahashi, K., Cohen, E. H., Wydro, R., Housman, D. E. and Kodama, T. (1990). Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A., 87,8810-8814.
31. Schaub, R. G., Donnelly, L. H., Parker, T. S., Clinton, S. K. and Garnick, J. B. (1995). The protective role of macrophages in atherogenesis: insight from using M-CSF. In: Atherosclerosis 10. Proceedings of the Tenth International Symposium on Atherosclerosis. (Woodford, F. P., Davignon, J. and Sniderman, A., eds.) Elsevier: Amsterdam, Lousanne, New York, Oxford, Shannon, Tokyo, pp. 537-544.
32. Price, L. K., Choi, H. U., Rosenberg, L. and Stanly, E. R. (1992). The predominant form of secreted colony stimulating factor-1 is a proteoglycan. J. Biol. Chem., 267, 21902199.
33. Blomhoff, R., Drevon, C. A., Eskild, W., Helgerud, P., Norum, K. R. and Berg, T. (1984). Clearance of acetyl low density lipoproteins by rat liver endothelial cells. Implications for hepatic cholesterol metabolism. J. Bio!. Chem., 259, 8898-8903.
34. Pitas, R. E., Boyles, J., Mahley, R. W. and Bissell, D. M. (1985). Uptake of chemically modified LDL in vivo is mediated by specific endothelial cells. J. Cell. Biol., 100, 103-117.
35. Berkel, T. J. C. V., Kijke, Y. B. D. and Kruijt, J. K. (1991). Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. J. Biol. Chem., 266, 2282-2289.